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Human amniotic fluid stem cells (AFSC) with multilineage differentiation potential are novel source for cell therapy. However,
in vitro expansion leads to senescence affecting differentiation and proliferative capacities. Reactive oxygen species (ROS) have
been involved in the regulation of stem cell pluripotency, proliferation, and differentiation. Redox-regulated signal transduction is
coordinated by spatially controlled production of ROS within subcellular compartments. NAD(P)H oxidase family, in particular
Nox4, has been known to produce ROS in the nucleus; however, the mechanisms and the meaning of this function remain largely
unknown. In the present study, we show that Nox4 nuclear expression (nNox4) increases during culture passages up to cell cycle
arrest and the serum starvation causes the same effect. With the decrease of Nox4 activity, obtained with plumbagin, a decline of
nuclear ROS production and of DNA damage occurs. Moreover, plumbagin exposure reduces the binding between nNox4 and
nucleoskeleton components, as Matrin 3. The same effect was observed also for the binding with phospho-ERK, although nuclear
ERK and P-ERK are unchanged. Taken together, we suggest that nNox4 regulation may have important pathophysiologic effects in
stem cell proliferation through modulation of nuclear signaling and DNA damage.
1. Introduction
Stem cells are characterized by a high capacity of self-
renewal and differentiation. Through self-renewal, stem cells
maintain the homeostasis of a stem cell pool; through dif-
ferentiation, stem cells can give rise to terminal cells with
diverse morphology and functions [1]. In tissues, most stem
cells are in the quiescent state, and they are protected by
special microenvironments (niches) [2]. The quiescence of
stem cells may prevent the accumulation of DNA replication
errors [3] and may facilitate resistance to many stressors [4].
The intracellular ROS level is a critical factor that regulates
the quiescent status of mesenchymal stem cells (MSC) [5].
Similar to the low partial pressure of oxygen, low levels of
ROS in niches are important for the stemness of MSC [6].
However, in vitro expansion of stem cells implies normoxic
culture condition.
Indeed, MSC proliferative and colony formation capac-
ity is significantly increased in normoxia. However, MSC
expanded under normoxia show a threefold to fourfold
increase in senescence, suggesting that hypoxia prevents
oxidative stress-induced senescence andpreservesMSC long-
term self-renewal [7].
Accumulation of ROS is a common occurrence in senes-
cent cells. Studies have shown that induction of ROS in
senescent cells is involved in inhibiting proliferation [8]. On





cent human fetal MSCs termed placenta-derivedmultipotent
cells (PDMCs) has been found, but the accumulation was





involved in altering the differentiation potential of senescent
PDMCs [9].
Various ROS-generating and ROS-degrading systems in
different compartments of the cell seem to play an important
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role. The nucleus itself contains a number of proteins with
oxidizable thiols that are essential for transcription, chro-
matin stability, and nuclear protein import and export, as
well as DNA replication and repair [10]. Specific isoforms
of glutathione peroxidases, glutathione S-transferases, and
peroxiredoxins are enriched in nuclei, further supporting
the interpretation that functions of the thiol-dependent
systems in nuclei are at least quantitatively and probably also
qualitatively distinct from similar processes in the cytoplasm
[11].
ROS generation within the nucleus may have several
important effects on cellular function. ROS can inactivate
nuclear-localized phosphatases and thereby enhance kinase
activation. For example, the oxidative inactivation of the
nuclear phosphatase mitogen-activated kinase phosphatase
1 regulates ERK1/2 activation [12]. Excessive production of
ROS could also lead to oxidative DNA damage.
In this point of view, the subcellular localization of
NADPH oxidase isoform 4 (Nox4) is likely to be especially
important, given its constitutive activity, unlike isoforms,
such as Nox1 or Nox2, that requires agonist activation. How-
ever, its subcellular distribution remains controversial, at least
in part attributable to the lack of sufficiently specific or char-
acterized antibodies. Nox4 has been reported to be variably
present in the ER [13, 14], mitochondria [15], cytoskeleton
[16], plasma membrane [17], and nucleus [18] in different cell
types.
Other unresolved questions include whether Nox4 uti-
lizes NADPH or NADH as a substrate to produce O
2
. [18, 19]
and whether it primarily produces superoxide or hydrogen
peroxide [18, 20].
More recently, endothelial nuclei have been shown to
produce ROS that are, at least in part, Nox4 dependent [18,
21], but its subnuclear localization (within specific nuclear
membranes) remains unclear [22]. Nuclear Nox4 has also
been implicated in DNA damage resulting from both heman-
gioendothelioma formation [23] and hepatitis C infection
[24].
NADPH oxidase Nox4 is a critical mediator in oncogenic
H-RasV12-induced DNA damage response [25]. DNA dam-
age response, detected by c-H2A.X foci analysis, leads to cell
aging and subsequent senescence [26].
Anilkumar et al. [27] found that there is a nuclear-
localized and functionally active splice variant of Nox4
(Nox4D) that may have important pathophysiologic effects
through modulation of nuclear signaling and DNA damage.
Interestingly, a significant proportion of nuclear Nox4D was
localized to the nucleolus of vascular cells.
In this study, we investigated the role of Nox4-derived
nuclear ROS on proliferative capacity of amniotic fluid stem
cells (AFSC) since they can be considered representative of
human stem cells, in view of their characteristics, such as the
intermediate status between embryonic stem cells and adult
stem cells.
Moreover, De Coppi and colleagues [28] described that
AFSC can be directed into a wide range of cell types repre-
senting the three primary embryonic lineages of mesoderm,
ectoderm, and definitive endoderm [29, 30]. Amniotic fluid
is known to contain a heterogeneous population of cell types
derived from fetal tissues and the amnion [31]. In vitro expan-
sion of human stem cells is necessary to obtain a sufficient cell
number to in vivo implant purpose, but it leads to senescence
affecting proliferative and differentiation capacities. Thus,
if the function of ROS is to enforce irreversible cellular
senescence, the NADPH oxidase Nox4, as ROS-generating
system, appears to be a potential nuclear ROS source.
Here, we show that a part of Nox4 localizes to the nucleus
of AFSC, where the oxidase likely forms a functional complex
with p22phox and produces ROS in the nucleoplasm. In
addition, Nox4 seems to regulate DNA damage, constituting
a part of oxidative stress. Here, we assessed the effect of
plumbagin, a plant-derived naphthoquinone directly inhibit-
ing Nox4 activity [32], on DNA damage and Nox4 nuclear
interactions.
2. Materials and Methods
2.1. Cell Culture. Amniocentesis samples (5 back up flasks
obtained from different donors) were provided by the Lab-
oratorio di Genetica, Ospedale Santa Maria Nuova (Reggio
Emilia, Italy). All samples were collected with informed
consent of the patients (mother’s age ≥ 35) according to
Italian law and ethical committee guideline.
Human AFSC were isolated as previously described by
De Coppi et al. [28]. Human amniocentesis cultures were
harvested by trypsinization and subjected to c-Kit immunos-
election by MACS technology (Miltenyi Biotec, Germany).
AFSC were subcultured routinely at 1 : 3 dilution and not
allowed to expand beyond the 70% of confluence. AFSC
were grown in culture medium (𝛼MEM supplemented with
20% fetal bovine serum (FBS), 2mM L-glutamine, 100U/mL
penicillin, and 100 𝜇g/mL streptomycin) (all from EuroClone
Spa, Italy) [33].
Cells were treated with plumbagin (5-hydroxy-2-methyl-
1,4 naphthoquinone) or diphenyleneiodonium (Sigma
Aldrich, St. Louis, MO,USA).
2.2. Cell Viability and Proliferation Assay. Viable cells were
evaluated by the MTT assay, since the reduction of tetra-
zolium salts is widely accepted as a reliable way to exam-
ine cell viability/proliferation. Cells were incubated with
0.5mg/mL MTT for 4 h at 37∘C, as previously reported [34].
At the end of the incubation, purple formazan salt crystals
were dissolved by adding the solubilization solution (iso-
propanol, 0.01M HCl). The absorption at 570 nm was mea-
sured on a multiwell plate reader (Appliskan, Thermo-Fisher
Scientific, Vantaa, Finland).
2.3. Cell Cycle Analysis. For detection and quantification of
cell cycle distribution, samples containing 2–5 × 105 cells
were harvested by centrifugation, fixed in cold ethanol, and
subjected to propidium iodide (Sigma Aldrich, St. Louis,
MO, USA) flow cytometric assay. Total lysates, obtained
as reported below, were subjected to Western blotting and
revealed for anticyclin E (Santa Cruz Biotechnology, Santa
Cruz, CA, USA).
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2.4. Preparation of Cell Extracts. Cell extracts were obtained
as described by Maraldi et al. [35]. Briefly, subconfluent cells
were extracted by addition of AT lysis buffer (20mMTris-Cl,
pH 7.0; 1% nonidet P-40; 150mM NaCl; 10% glycerol; 10mM





) and freshly added Sigma Aldrich protease inhibitor
cocktail at 4∘C for 30min. Lysates were sonicated, cleared by
centrifugation, and immediately boiled in SDS sample buffer
or used for immunoprecipitation experiments, as described
below.
2.5. Immunoprecipitation and Electrophoresis. Immunopre-
cipitation was performed as reported by Cenni et al. [36].
Equal amounts of precleared lysates, whose protein con-
centration was determined by the Bradford method, were
incubated overnight with anti-NOX4 (Novus Biologicals,
CO, USA), antipan 14.3.3 (Santa Cruz Biotechnology, Santa
Cruz, CA,USA) (3 𝜇g all).Then, the two samples were treated
with 30 𝜇L of 50% (v/v) of protein A/G agarose slurry (GE
Healthcare Bio-sciences, Uppsala, Sweden) at 4∘Cwith gentle
rocking for 1 h. Pellets were washed twice with 20mM Tris-
Cl, pH 7.0; 1% Nonidet P-40; 150mM NaCl; 10% glycerol;
10mMEDTA; 20mMNaF; and 5mMsodiumpyrophosphate
and once with 10mM Tris-Cl, pH 7.4, boiled in SDS sample
buffer, and centrifuged. Supernatants were loaded onto SDS-
polyacrylamide gel, blotted on Immobilon-P membranes
(Millipore, Waltham, MA, USA), and processed by Western
blot with the indicated antibodies, detected by Supersignal
substrate chemiluminescence detection kit (Pierce, Rockford,
IL, USA). Quantitation of the signal was obtained by chemi-
luminescence detection on aKodak Image Station 440CF and
analysis with the Kodak 1D Image software.
2.6. Nuclei Purification. Human AFSC nuclei were purified
as reported by Cenni et al. [37]. Briefly, to 5 × 106 cells
400𝜇L of nuclear isolation buffer was added (10mM Tris-
HCl, pH 7.8, 1% Nonidet P-40, 10mM 𝛽-mercaptoethanol,
0.5mM phenylmethylsulfonyl fluoride, 1 𝜇g/mL aprotinin
and leupeptin, and 5mM NaF) for 8min on ice. MilliQ
water (400 𝜇L) was then added to swell cells for 3min. Cells
were sheared by passages through a 22-gauge needle. Nuclei
were recovered by centrifugation at 400×g at 4∘C for 6min
and washed once in 400𝜇L of washing buffer (10mM Tris-
HCl, pH 7.4, and 2mM MgCl
2
, plus inhibitors as described
earlier in the text). Supernatants (containing the cytosolic
fractions) were further centrifuged for 30min at 4000×g.
Isolated nuclear and cytoplasmic extracts were finally lysed
in AT lysis buffer, sonicated, and cleared by centrifugation.
2.7. Western Blot. The protocols of the western blot were
performed as described by Hanson et al. [38].
Protein extracts, quantified by a Bradford Protein Assay
(Bio-Rad Laboratories, CA, USA), underwent to SDS-
polyacrylamide gel electrophoresis and were transferred to
Immobilon-P membranes. The following antibodies were
used: rabbit antipan 14.3.3, rabbit anticyclin E, rabbit anti-
Nox4, rabbit anti-Ki67, Rabbit anti-ERK1/2, goat anti-Matrin
3, goat anti-actin, anti-p22phox (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) diluted 1 : 500, rabbit anti-p44/42
ERK1/2 (Cell Signalling Technology, Beverly, MA, USA),
mouse anti-Tubulin (Sigma Aldrich St. Louis, MO, USA),
rabbit anti-Nox4 (Abcam, Cambridge, UK), rabbit anti-
Nox4 (Novus Biologicals, CO, USA), and mouse anti-pH2A
(Ser139) (Millipore, Billerica, MA, USA) diluted 1 : 1000;
peroxidase-labelled anti-rabbit, mouse, and goat secondary
antibodies diluted 1 : 3000 (Pierce Antibodies,Thermo Scien-
tific; Rockford, IL, USA). Ab dilution was performed in TBS-
T pH 7.6 containing 3% BSA.Themembranes were visualized
using Supersignal substrate chemiluminescence detection kit
(Pierce, Rockford, IL, USA). Antiactin antibody was used as
control of protein loading.
2.8. Confocal Microscopy. Undifferentiated AFSC were fixed
for 20min in 4% ice-cold paraformaldehyde and then per-
meabilized with 0.1% Triton X-100 in ice-cold phosphate-
buffered saline (PBS) for 5min. Permeabilized samples were
then blocked with 3% of bovine serum albumin (BSA) in PBS
for 30min at room temperature and incubated with primary
antibodies (Abs). Rabbit anti-Nox4, goat anti-Matrin 3, rabbit
anti-Ki67 (Santa Cruz, CA, USA) (diluted 1 : 50), and mouse
anti-pH2A (Ser139) (Millipore, Billerica, MA, USA) (diluted
1 : 100), in PBS containing 3% BSA for 1 h at RT were used
as primary antibodies (Ab). Secondary Ab was diluted 1 : 200
in PBS containing 3% BSA (goat anti-mouse Alexa 647, goat
anti-rabbit Alexa 488, and donkey anti-goat Alexa 488). After
washing in PBS, samples were stained with 1𝜇g/mL DAPI in
H
2
O for 1min and then mounted with antifading medium
(0.21M DABCO and 90% glycerol in 0.02M Tris, pH 8.0).
Negative controls consisted of samples not incubatedwith the
primary antibody, but only with the secondary antibody.
Confocal imaging was performed on a Nikon A1 confocal
laser scanning microscope as previously described [39].
Spectral analysis was carried out to exclude overlapping
between two signals or the influence of autofluorescence
background on the fluorochrome signals, as previously
shown [40]. The confocal serial sections were processed with
ImageJ software to obtain three-dimensional projections, as
previously described [41]. The image rendering was per-
formed by Adobe Photoshop software.
2.9. Nuclear ROS Imaging. Nuclear ROS were detected with





Emerald 1 (NucPE1) [42–45]. For all experiments, 5𝜇M
solutions of NucPE1 (from 5mM stocks in DMSO) were
made in PBS/glucose.The cells were then kept in an incubator
(37∘C, 5% CO
2
) during the course of all experiments. The
probes were incubated for total 30min. Fluorescence was
measured on a multiwell plate reader (Appliskan, Thermo
Scientific) using 488 nm filter for excitation and 535 nm filter
for emission.
Confocal fluorescence imaging studies were performed
with a Nikon A1 confocal laser scanning microscope. Excita-
tion ofNucPE1-loaded cells at 488 nmwas carried out with an
Ar laser and emission was collected at 535 nm. All images in
an experiment were collected simultaneously using identical
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microscope settings. Image analysis was performed in Image
J.
2.10. Statistical Analysis. In vitro experiments were per-
formed in triplicate. For quantitative comparisons, values
were reported as mean ± SD based on triplicate analysis for
each sample. To test the significance of observed differences
between the study groups, unpaired Student’s t-test was
applied. A 𝑃 value < 0.05 was considered to be statistically
significant.
3. Results and Discussion
3.1. Nox4 Expression in AFSC. At first we noticed that amni-
otic fluid stem cells express NADPH isoform 4 Nox4 both
into the nucleus and in the cytoplasm, unlike Nox1 and Nox2
(data not shown). We tested different antibodies directed to
Nox4 protein in order to verify this observation. In fact,
in the literature, a homemade antibody anti-Nox4 is often
used (polyclonal Nox4 antibodies by the Lambeth and Shah
groups are themost frequently used) (see review [46]).On the
other hand, all the employed antibodies revealed a variable
percentage of cells with a nuclear localization of Nox4
(Figure 1(a)) and this data is consistent with other studies in
which Nox4 has been found in nuclear or perinuclear area
[18, 25, 47, 48]. By using antibodies from Santa Cruz, Abcam,
or Novus, we can see a signal mostly localized inside the
nuclei, not in the nuclear envelope, as demonstrated inmouse
liver cells [48]. Regarding the staining obtained with Abcam
antibody, all the nucleoplasm is marked except for nucleoli.
Novus antibody binds other perinucleolar domains, while
Santa Cruz antibody shows a more punctate pattern.
In order to investigate the NADPH oxidase activity inside





Peroxy Emerald 1 (Figure 1(b)). Detection of nuclear ROS
production with this probe demonstrates that ROS sources
inside the nuclei have a punctate pattern similar to the one of
Nox4 from Santa Cruz. Therefore, for immunofluorescence
analysis, we utilized this antibody.
The same analysis has been performed for Western blot
experiments (Figure 2(a)). Total lysates, cytosol, and nuclear
fractions and the three antibodies reported above were tested.
WB analysis with all the antibodies of nuclear and cyto-
plasmic fractions confirmsNox4 presence both in cytosol and
nuclei. Incubationwith all the three antibodies reveals a triple
band between 50 and 75 kDa, even if the band intensity is
different depending on the antibody. In WB, the antibody
from Novus seems to recognize the nuclear Nox4 (nNox4)
better than others, since the bands in nuclear protein fraction
are the most intense (Figure 2(a)).
The Novus antibody works also in immunoprecipitation
experiment. Figure 2(b) shows nuclear extracts (NL) used for
coimmunoprecipitation analysis with anti-Nox4 (IPNox4).
This experiment confirms the presence of Nox4 in nuclear
proteins showing the interaction between Nox4 and the
modulatory subunit p22phox. Furthermore, Nox4 seems to
be linked with nuclear matrix protein, Matrin3, and with
the mitogen-activated protein kinase ERK1/2, suggesting
(a)
(b)
Figure 1: Immunofluorescence analysis of Nox4 expression and
nuclear ROS in AFSC. (a) Representative images showing super-
imposing between DAPI (blue) and Nox4 (green) signals obtained
with antibody from Novus (Nov), Abcam (Abc), and Santa Cruz
(SC). Inside all the three images, a square showing magnification
of a cell with only the Nox4 signal in green is present. The highest
magnification of one nucleus is shown for Santa Cruz labelling. (b)
Representative images showing staining with nuclear ROS probe
(Nuclear peroxy Emerald 1). Scale bar: 10 𝜇m.
a direct role in nuclear MAPK signaling regulation. It has
been previously demonstrated that ERK activation (phos-
phorylation) occurs downstream from the Nox4 pathway:
in particular through the Ras activation in endoplasmic
reticulum of Human umbilical vein endothelial cells [49] or
by a Src/caveolin-mediated activation in renal tubular cells
[50].
3.2. Modulation of Nox4 Presence into the Nuclei. The ERK
cascade is involved in cellular proliferation, differentiation,
and survival. In fact nuclear translocation of ERK1 and ERK2
is critical for both gene expression and DNA replication
induced by growth factors [51].Moreover, in the nucleus, ERK
phosphorylates an array of targets, including transcription
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Figure 2: Nox4 expression in subcellular compartment of AFSC. (a) Representative images of Western blot analysis of total lysates (TL),
cytosol (cyto) and nuclear fractions (nuclei) of AFSC revealed with different Nox4 antibodies: Santa Cruz (SC), Abcam (Abc), and Novus
(Nov). Tubulin is shown as marker of nuclei purification. (b) Western blot analysis of nuclear lysate (NL) and immunoprecipitation
experiment of NL with Nox4 antibody from Novus revealed with anti-Matrin, anti-Nox4, anti-ERK1/2, and anti-p22phox. Presented data
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Figure 3: Effect of serum presence on Nox4 localisation end nuclear ROS production. (a) Representative images showing superimposing
betweenDAPI (blue) andNox4 SC (green) signals of AFSC cultures in the presence of absence of serum (FBS). Arrows indicate Nox4 staining
in the nuclei. (b) Representative images ofWestern blot analysis revealedwithNox4 fromNovus of cytosol and nuclei fractions of AFSC grown
in the presence or absence (for 24 hours) of FBS. Actin and tubulin detectionwere performed in order to show the amount of protein loaded in
each line and the nuclear fraction purity, respectively. Presented data are representative of three independent experiments. (c) Representative
images showing staining with nuclear ROS probe (Nuclear peroxy Emerald 1) of AFSC with or without serum. Scale bar: 10 𝜇m.


















































Figure 4:Nox4 localisation during culture passages. (a) Cytofluorimetric analysis with propidium iodide (PI) ofAFSC in culture frompassage
1 to 12. Representative FACS analysis of cells at passages 6 and 12.The graph shows the percentage of cells on S phase. (b) Representative images
ofWestern blot analysis of cytosol and nuclei of AFSC frompassages 7 to 12 and revealedwithNox4 fromNovus, Cyclin E, and actin. Presented
data are representative of three independent experiments. (c) Representative images showing superimposing between DAPI (blue) and Nox4
SC (green) signals of AFSC cultures at passages 8, 10, and 12. Arrows indicate Nox4 staining in the nuclei. Scale bar: 10 𝜇m.
factors involved in multiple aspects of growth control. Based
on these considerations, we investigated the effect of prolifer-
ation stimuli onNox4 localization in AFSC. AFSC are usually
grown in the presence of 20% serum in order to induce the
best proliferation rate. Serum starvation (−FBS) in fact affects
Nox4 distribution within the cell. As demonstrated by WB
and IF analysis shown in Figures 3(a) and 3(b), the nuclear
portion of Nox4 (nNox4) increases in AFSC cultured without
FBS for 24 hours. In fact, confocal images show the Nox4
punctate pattern in the majority of nuclei in–FBS sample.
Serum deprivation induces also a decrease in Nox4 staining
in the cytosol (Figures 3(a) and 3(b)), compared to +FBS
sample.
This observation is consistent with data obtained with the
fluorogenic probe assay for nuclear ROS. In fact the number
of nuclei strongly stained with the probe is higher in culture
−FBS (Figure 3(c)). The nuclear ROS quantification shows
that the increase of fluorescence intensity in the absence of
FBS is around 50%.
Amniotic fluid stem cells, after a week of slow pro-
liferation in culture, can be passaged at 70% confluence
every two to three days. As mesechymal stem cells, they can
rapidly react to changes of the culture environment during
expansion. In particular, MSC have been proved to gradually
become senescent and decrease their proliferative capacity
while in culture. The proliferation curve of AFSC in our
































































Figure 5: Effect of plumbagin on AFSC proliferation. (a) AFSC (between the 6th and at 8th passages) were incubated for 24 hours with
increasing concentration of plumbagin (0–5𝜇M). Cell viability was determined with the MTT test, as described in the Material andMethods
section. ∗∗∗𝑃 < 0.0001; ∗∗𝑃 < 0.01; ∗𝑃 < 0.05 significantly different from control cells. (b) Cytofluorimetric analysis with propidium iodide
(PI) of AFSC in culture frompassages 8 to 12 in the presence or absence of 2𝜇Mplumbagin.The graph shows the percentage of cells on S phase.
Presented data are representative of three independent experiments. ∗𝑃 < 0.05 significantly different from control cells. (c) Representative
images showing superimposing betweenDAPI (blue) andKi67 (green) signals of AFSC cultures at passages 8 and 12 in the presence or absence
of 2 𝜇M plumbagin for 24 hours. Scale bar: 10𝜇m.
experimental condition is shown in Figure 4(a), where the
percentage of cells in S phase is graphed. After the first 3-4
passages of slow growth, an increase in proliferation occurs
up to a plateau state around the 8th passage; hence, the
number of cells able to divide decreases quickly.
Western blot analysis of AFSC during late passages
(Figure 4(b)) shows that nuclear Nox4 presence dramatically
increases at cell cycle arrest, decreasing the cytosol. Indeed
confocal images show the Nox4 punctate pattern in the
majority of nuclei in sample at 12th passage. In fact, while
Cyclin E expression decreases at 12th passage, indicating a
stop in proliferation, Nox4 raises in nuclear fraction. The
same trend can be observed by IF analysis, as shown in
Figure 4(c).
3.3. Effect of Nox4 Inhibition on AFSC Proliferation. In order
to evaluate the effects of Nox4 inhibition on cell viabil-
ity/proliferation, we used plumbagin, a plant-derived naph-
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(a)
(b)
Figure 6: Effect of Nox4 inhibition on nuclear ROS production and DNA damage. (a) Representative images showing staining with nuclear
ROS probe (Nuclear peroxy Emerald 1) of AFSC in the presence or absence of 2𝜇M plumbagin or 1 𝜇M DPI for 24 hours. Scale bar: 10𝜇m.
(b) Representative images showing superimposing between Nox4 SC (green) and PH2A (red) signals with or without DAPI (blue) of AFSC
in the presence or absence of 2 𝜇M plumbagin or 1 𝜇MDPI for 24 hours. Arrows indicate the PH2A staining in the nuclei. Scale bar: 10 𝜇m.
thoquinone, directly interacting with Nox4 and inhibiting
its activity [31]. MTT test shows that 1-2𝜇M plumbagin
does not affect negatively cell viability, but rather, at 2 𝜇M
concentration plumbagin is able to significantly improve cell
proliferation. At higher concentrations, plumbagin decreases
AFSC viability around 50–60% after 1 day of incubation
(Figure 5(a)); therefore, these concentrationswere not chosen
for the reported experiments.
Moreover, late passages (8–12 p) AFSC cultured in the
presence of 2𝜇M plumbagin display a better proliferation
trend, as shown in graph of phase S cells (Figure 5(b)), even
if not always in a significant manner. The same indication is
provided by IF experiment of Ki-67 staining during culture
passages (Figure 5(c)). The expression of the human Ki-
67 protein is strictly associated with cell proliferation. The
number of nuclei positive for Ki-67 is dramatically reduced
in sample of late passage. In the presence of plumbagin, the
staining of Ki-67 is higher both at 8th and 12th passages,
compared to control samples.
Even if the use of Nox4 synthetic or natural inhibitors,
diphenyleneiodonium (DPI) and Plumbagin, is not directed
to the nuclear part of Nox4, as demonstrated by the flu-
orogenic probe assay, the Nox4 activity inhibition reduces
the nuclear ROS production (Figure 6(a)). The nuclear ROS
quantification shows that the decrease of fluorescence inten-
sity in the presence of DPI or plumbagin is around 50% for
both. This effect can regulate cell proliferation also through a
modulation of DNA stability. In fact, ROS can also activate
both cell survival and senescence pathways depending on
its concentration and localization [52–54]. To assess whether
nNox4-generated ROS can induce nuclear DNA damage, we
studied nuclear H2A foci. It has been shown recently that
the status of H2AX phosphorylation is crucial to determine
whether cells will survive after DNA damage [55].
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Figure 7: Effect of plumbagin on Nox4 nuclear interaction. (a) Representative images of Western blot analysis of total lysates of AFSC
treated with 2𝜇M plumbagin or 1 𝜇M DPI for 24 hours. Membranes were revealed with anti-Nox4, anti-PERK1/2, and antiactin. (b)
Subcellular fractions obtained with the plumbagin treatment were prepared for immunoprecipitation analysis. Nuclear lysate (NL) were
immunoprecipitated with Nox4 antibody from Novus then revealed with anti-Matrin, anti-Nox4, and anti-PERK1/2. (c) Nuclear lysate
(NL) were immunoprecipitated with anti-14-3-3 then revealed with anti-Nox4 and anti-14-3-3. All presented data are representative of three
independent experiments. (d) Representative images showing superimposing between Matrin 3 (green) and Nox4 (red) signals of AFSC in
the presence or absence of 2𝜇M plumbagin for 72 hours. Scale bar: 10𝜇m.
The ROS production decrease, obtained with syn-
thetic or natural Nox4 inhibitors (DPI and Plumbagin),
reduces the staining for the phosphorylated form of histone
H2AX, marker of oxidative stress derived-DNA damage
(Figure 6(b)).
3.4. Effect of Plumbagin on Nox4 Nuclear Interaction. We
investigated the effect of Nox4 inhibition on the previously
observed nuclear Nox4 binding network (Figure 2(b)). The
Nox4-derived ROS decrease, obtained with DPI or plumba-
gin incubated for 24 hours, reduces the expression of ERK
in total lysates, but the P-ERK level remains unchanged
(Figure 7(a)). Coimmunoprecipitation experiment for Nox4
shows that, in the presence of plumbagin, Nox4 binding with
P-ERK decreases (Figure 7(b)). This data confirms the link
between Nox4 and ERK1/2 within the nucleus, as shown also
in VSMC where Nox4 specifically increased nuclear phos-
phorylated ERK1/2 [27] but emphasizes the direct association
and the modulation of this nuclear kinase in the active form
by the ROS source, Nox4.
Also the interaction with some nucleoskeleton molecules
seems to be modulable by Nox4 inhibition. In fact, CoIP for
Nox4 shows a decrease in matrin 3 binding in sample treated
with plumbagin (Figure 7(b)). Matrin 3, an abundant protein
of the internal nuclear matrix, has been linked to a variety
of functional events. While many sites occurred proximal
to nucleoli, no significant staining was detected within the
nucleolar interior. On the other hand, matrin 3 has been
demonstrated to bind DNA at sites termed scaffold/matrix
attachment regions to regulate gene expression through
interactions with chromatin remodeling. Matrin 3 has been
involved also in transcriptome machinery through RNA
processing and structural organization [56]. Matrin 3 could
be a docking site where nuclear ROS signaling may exert its
function on transcription/pre-mRNAmodulation in specific
nuclear domains.
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14-3-3 proteins have the ability to bind a multitude of
functionally diverse signaling proteins, including kinases,
phosphatases, playing important roles in a wide range of vital
regulatory processes, such as mitogenic signal transduction
and cell cycle control.
There are common themes by which 14-3-3 proteins
regulate different signaling pathways. 14-3-3 can control the
location of proteins by preventing nuclear import/export or
membrane translocation or both.Moreover, 14-3-3may com-
pete with other signaling proteins for binding on the target
protein and may modulate its substrate from ubiquitination
and degradation [57].
The effect of Nox4 activity inhibition by plumbagin could
cause a Nox4 sequestration by 14-3-3 binding, as shown by
CoIP experiment for 14-3-3 (Figure 7(c)). In fact, a longer
incubation (72 h) with plumbagin induces a decrease in Nox4
presence inside nuclei, while matrin 3 pattern is unchanged
(Figure 7(d)). Indeed, the image shows the double staining
for matrin3 (green) and Nox4 (red). In the control case,
the superimposing produces an orange staining, indicating
the presence of high red signal, while in the sample with
plumbagin the superimposing causes only a green staining,
due to the anti-Matrin 3 labeling.
4. Conclusions
We observed that Nox4 isoform is expressed in human AFSC
and, interestingly, it localizes into the nucleus. Confocal anal-
ysis demonstrates Nox4 presence in nucleoplasm domains,
not only in nuclear membranes, suggesting that Nox4 could
be involved in regulatingDNA-mRNAprocessingmachinery
by ROS production in specific nuclear area. During culture
passages up to cell cycle arrest, AFSC exhibit a proliferation
rate inversely coupled with Nox4 presence into the nuclei.
Furthermore, the serum starvation causes the same effect.
Moreover, immunoprecipitation analysis demonstrated that
Nox4 interacts with ERK signaling, suggesting a role in
nuclear signaling pathways.
Inhibition of Nox4 activity, obtained with plumbagin,
induces a decline of nuclear ROS production and of DNA
damage. Moreover, plumbagin exposure reduces the bind-
ing between nNox4 nucleoskeleton components. The same
effect was observed also for the binding with phospho-
ERK, although nuclear ERK and P-ERK are unchanged.
A longer incubation with plumbagin may modulate Nox4
nuclear expression, by controlling the protein localization
or/and a degradation pathway involvement. Taken together,
we suggest that nNox4 regulation may have important
pathophysiologic effects in stem cell proliferation through
modulation of nuclear signaling and DNA damage.
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